The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Veeva Systems is the larger company, worth $50.7B, about 9.3 times MiniMed.
  • Veeva Systems grew revenue faster over the last year (+17.6% vs +16.6%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureMMEDVEEV
Market cap$5.5B$50.7B
Share price$19.71$296.13
Revenue (last fiscal year)$3.1B$3.2B
Free cash flow (last fiscal year)-$420M$1.4B
Revenue growth, last year+16.6%+17.6%
Revenue growth per year, last 5 fiscal years+12.1%+14.6%
Operating margin—29.9%
Net margin—29.3%
Return on equity-8.5%13.7%
P/E (trailing)—57.1x
Price / free cash flow—36.6x
EV / EBITDA72.3x21.7x
FCF growth the price implies—12.9%
Dividend yield——
Debt / equity0.30x0.22x
Fundamental gradeDB
Superinvestors holding it06
Insider purchases, last 12 months00

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

MiniMed

YearRevenueFree cash flowOp. margin
2024$2.5B-$107M-2.8%
2025$2.7B-$53M-5.4%
2026$3.1B-$420M-6.1%

Veeva Systems

YearRevenueFree cash flowOp. margin
2022$1.9B$750M27.3%
2023$2.2B$767M21.3%
2024$2.4B$885M18.2%
2025$2.7B$1.1B25.2%
2026$3.2B$1.4B28.7%

Where the revenue comes from

MiniMed · by products, 2026

CGM$1.6B50%
Consumables$956M31%
Pumps$546M18%
Other$46M1%

Veeva Systems · by products, 2026

R&D and Quality Solutions$1.4B45%
Commercial Solutions$1.3B39%
R&D and Quality Solutions$322M10%
Commercial Solutions$189M6%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open MMED in Investingly

Questions

Which is bigger, MiniMed or Veeva Systems?

Veeva Systems (VEEV), at $50.7B against $5.5B.

Which grows faster, MMED or VEEV?

Veeva Systems: revenue grew +17.6% over the last year, against +16.6%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.